Alembic Pharmaceuticals recalls 10mg Doxepin capsules due to nitrosamine impurity exceeding safety limits. This prescription drug may pose health risks if consumed. Consumers should contact the manufacturer for details.
“Alembic Doxepin Capsules Recall: Nitrosamine Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31956-alembic-doxepin-capsules-recall-nitrosamine-impurity-risk. Based on FDA recall #D-0566-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0566-2025%22&limit=1).
Alembic Pharmaceuticals Limited voluntarily recalled Doxepin Hydrochloride Capsules, USP, 10 mg, following CGMP deviations involving a nitrosamine impurity above the proposed interim limit, according to the FDA on July 25, 2025.
The recall addresses CGMP deviations due to the presence of a nitrosamine drug substance related impurity above the proposed interim limit, according to the FDA.
Context
GovInfoNow's records show Alembic Pharmaceuticals Limited has 6 other recalls on record since June 10, 2020. Other recent recalls of similar products include Asclemed Duloxetine Capsules Recall: Nitrosamine Impurity Risk (May 14, 2026), Appco Pharma Prazosin Capsules Recall: Nitrosamine Impurity Risk (March 27, 2026), and Zydus Clomipramine Capsules Recall: Nitrosamine Impurities Risk (October 22, 2025).
How to tell if you have this one
Check for the product name 'Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules' with NDC code 62332-637-31 and lot number 2305015142. These were manufactured in India and distributed in the US by Alembic Pharmaceuticals.
Brand
Alembic
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the NDC code 62332-637-31 and lot number 2305015142 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 19 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0566-2025 (July 25, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0566-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.